Lumateperone and lemborexant
The Carlat Psychiatry Report, Volume 18, Number 3, March 2020
https://www.thecarlatreport.com/newsletter-issue/tcprv18n3/
Issue Links: Learning Objectives | Editorial Information
Topics: Antipsychotics | Belsomra | Caplyta | Dayvigo | Hypnotics | Lemborexant | Lumateperone | News of Note | Orexin | Pharmacology | Psychopharmacology | Suvorexant
The antipsychotic lumateperone (Caplyta) and the hypnotic lemborexant (Dayvigo) are the newest in their class. Both of them claim to improve on the safety of older medications, and we look at the data to see how those claims hold up.
You can't view details of this content, please login or buy subscription here